Nexalin Technology, Inc.
Datakwaliteit: 100%
NXL
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
€ 0,41
▼
€ 0,02
(-4,41%)
Marktkapitalisatie: 8,27 M
6 months return
—
Momentum
Neutral
ROE
-153,23%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -4,96 M
Price History
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)78,78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-153,23%
Onder sectorgemiddelde (-54,47%)
ROIC-123,54%
Net Margin-2725,76%
Op. Margin-2781,69%
Veiligheid
Debt / Equity
N/A
Current Ratio13,47
Interest Coverage-1018,31
Waardering
PE (TTM|NTM)
-1,01 | -1,30
Boven sectorgemiddelde (-1,49)
P/B Ratio1,73
EV/EBITDAN/A
Dividend YieldN/A
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,0 | -1,5 |
| P/B | 1,7 | 1,6 |
| ROE % | -153,2 | -54,5 |
| Net Margin % | -2725,8 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
1 analist
Consensus van analisten: gemiddeld koersdoel vs huidige prijs en beoordeling.
Strong Buy
Huidig
€ 0,41
Koersdoel
€ 2,00
€ 2,00
€ 2,00
€ 2,00
Vooruitzicht
Forward K/W
-1,30
Forward WPA
-€ 0,31
Omzet Sch.
690.000,0
Winstschattingen
Analistprognoses voor EPS en omzet per periode. Jaar = boekjaren; kwartaal = komende kwartalen.
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,31
-€ 0,31 – -€ 0,31
|
690.000,0 | 1 |
| FY2026 |
-€ 0,35
-€ 0,35 – -€ 0,35
|
345.000,0 | 1 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,09
-€ 0,09 – -€ 0,09
|
90.000,0 | 1 |
| 2026 Q1 |
-€ 0,10
-€ 0,10 – -€ 0,10
|
15.000,0 | 1 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,12 | -€ 0,13 | -8,3% |
| Q32025 | -€ 0,12 | -€ 0,13 | -8,3% |
| Q22025 | -€ 0,14 | -€ 0,10 | +28,6% |
| Q12025 | -€ 0,10 | -€ 0,15 | -50,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 78,78% | Revenue Growth (3Y) | 65,04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 301.647,0 | Net Income (TTM) | -8,22 M |
| ROE | -153,23% | ROA | -140,67% |
| Gross Margin | 79,65% | Operating Margin | -2781,69% |
| Net Margin | -2725,76% | Free Cash Flow (TTM) | -4,96 M |
| ROIC | -123,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 13,47 |
| Interest Coverage | -1018,31 | Asset Turnover | 0,05 |
| Working Capital | 4,46 M | Tangible Book Value | 4,46 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,01 | Forward P/E | -1,30 |
| P/B Ratio | 1,73 | P/S Ratio | 27,42 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 11,99 | Fwd Earnings Yield | N/A |
| FCF Yield | -59,95% | ||
| Market Cap | 8,27 M | Enterprise Value | 7,68 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,50 | Revenue / Share | 0,01 |
| FCF / Share | -0,24 | OCF / Share | -0,24 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 60,30% |
| SBC-Adj. FCF | -8,79 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 301.647,0 | 168.721,0 | 110.748,0 | 1,32 M |
| Net Income | -8,22 M | -7,61 M | -4,65 M | -1,70 M |
| EPS (Diluted) | -0,50 | -0,83 | -0,63 | — |
| Gross Profit | 240.274,0 | 132.128,0 | 85.060,0 | 958.145,0 |
| Operating Income | -8,39 M | -7,75 M | -5,70 M | -1,83 M |
| EBITDA | — | — | — | — |
| R&D Expenses | 1,08 M | 1,19 M | 1,92 M | 511.000,0 |
| SG&A Expenses | 4,40 M | 4,23 M | 3,82 M | 1,49 M |
| D&A | — | — | — | — |
| Interest Expense | -8.240,0 | -3.193,0 | 38.835,0 | 59.382,0 |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 4,64 M | 4,22 M | 3,63 M | 7,43 M |
| Total Liabilities | 887.333,0 | 546.694,0 | 425.281,0 | 1,95 M |
| Shareholders' Equity | 3,75 M | 3,68 M | 3,21 M | 5,48 M |
| Total Debt | — | — | — | — |
| Cash & Equivalents | 654.783,0 | 574.485,0 | 580.230,0 | 162.743,0 |
| Current Assets | 4,30 M | 3,96 M | 3,43 M | 7,43 M |
| Current Liabilities | 887.333,0 | 546.694,0 | 425.281,0 | 1,95 M |
{"event":"ticker_viewed","properties":{"ticker":"NXL","listing_kind":"stock","pathname":"/stocks/nxl","exchange":"NASDAQ","country":"US"}}

